Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lystek International is an environmental biotechnology company specializing in the sustainable management of biosolids and organic waste. The company utilizes a patented, low-temperature Thermal Hydrolysis Process (THP) to convert municipal and industrial wastewater sludge into high-quality, nutrient-rich biofertilizer products marketed as LysteGro. Their technology also enhances anaerobic digestion and provides carbon sources for biological nutrient removal in wastewater treatment plants. Headquartered in Canada, Lystek serves municipal and industrial clients across North America, focusing on resource recovery and the circular economy. The company was acquired by Logistec Corporation in 2021, further integrating its solutions into broader environmental services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lystek International.